Case Vignettes ANSWER KEY
|
|
- Henry Hall
- 5 years ago
- Views:
Transcription
1 Case Vignettes ANSWER KEY CASE 1 Cesar, an 8 year old, 38 kg Hispanic boy, presents to your office, transferring care from another PCP across town. He presents with complaints of significant hyperactivity, impulsivity, and defiance that are problematic at home and school. Records have yet to be received from his previous provider s office but reportedly previously diagnosed with ADHD and ODD at 6 ½ years of age. Mom expresses disappointment with previous medication trial of methylphenidate that was ineffective. She recalled he had been prescribed a once daily medication and he had to swallow the capsule whole. Dose was started at 18 mg but even at 27 mg it was still ineffective so mom stopped giving it. She wants to consider another trial of medication since he is still performing poorly in school and behaving badly both at home and school. 1) What is the most likely reason that initial trial of MPH failed? He was likely underdosed and MPH can be titrated all the way to 2 mg/kg/day. If MPH was adequately tolerated previously would you retry it? Yes. If MPH was not adequately tolerated is it time to consider a nonstimulant option? Not yet since generally need failed trials with both MPH and AMP (secondary to unsatisfactory symptoms response at MAXIMUM dosage or intolerable side effects). 2) Review of parent and teacher Vanderbilt rating scales revealed the following? VANDERBILT REPORT: PARENT: Symptoms of Inattention (i.e., items with score = 2 or 3): 6 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 7 out of 9 TOTAL SCORE: 13 (4 symptoms of ODD) TEACHER: Symptoms of Inattention (i.e., items with score = 2 or 3): 8 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 5 out of 9 TOTAL SCORE: 13 (0 symptoms of ODD) Which is the most accurate diagnostic impression based on data gathered? a) Cesar continues with to evince both features of ADHD and ODD at home and school. b) Cesar continues to evince features of ADHD both at home and school but the more disruptive behaviors exclusive to domestic settings. c) Cesar s ADHD symptomatology appears subthreshold to meet criteria for formal diagnosis. 3) Mother expresses some hesitancy about medication use and asks you if it is necessary. Review of Vanderbilt rating scales from both parent and home reveal functional impairment due to ADHD related behaviors appears to be significant both at home and school to warrant medication management. Above Somewhat of a Classroom Behavioral Performance Excellent Average Average Problem Problematic Relationship with peers Following directions Disrupting Class Assignment completion Organizational Skills PERFORMANCE SEVERE MODERATE MILD NOT AT ALL Academic Work
2 Study Habits Attitude Towards Teacher Peer Relationships a) True b) False 4) Upon further inquiring about his academic struggles, you discover that Cesar failed last years end of grade testing in reading and he passed to the third grade because of summer school. Currently, teacher responses on modified Vanderbilt indicate? Circle all that apply IEP Y N or 504 Y N EC Pullout to: Inclusion Self Contained For what purpose? Title 1 OT PT ST RtI : Tier 1 Tier 2 Tier 3 Has child had educational testing? Comments: a) No Section 504 Plan has been formulated for ADHD related behaviors. b) No prior psychoeducational evaluation has been completed to rule out learning issues. c) Currently no RtI for academic intervention has been implemented 5) Based on Cesar s current weight and previously reported adequate tolerance to medication, you recommend retrying once daily formulation of MPH at higher dosing so as to continue titration of dose for optimal effect. You prescribe Concerta 27 mg once daily for 1 week and then increase to 54 mg once daily thereafter. Based on follow up Vanderbilt rating scales, there is notable improvement at school but home is another matter. He is also now experiencing mild insomnia. VANDERBILT REPORT: PARENT: Symptoms of Inattention (i.e., items with score = 2 or 3): 4 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 4 out of 9 TOTAL SCORE: 8 (2 symptoms of ODD) TEACHER: Symptoms of Inattention (i.e., items with score = 2 or 3): 2 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 2 out of 9 TOTAL SCORE: 4 (0 symptoms of ODD) Academic Performance 2 years below grade level 1 2 years below grade level At grade level 1 2 years above grade level 2 years above grade level
3 Reading Writing Spelling Math Above Somewhat of a Classroom Behavioral Performance Excellent Average Average Problem Problematic Relationship with peers Following directions Disrupting Class Assignment completion Organizational Skills Comments : IEP Y N or 504 Y N EC Pullout to: Inclusion Self Contained For what purpose? Title 1 OT PT ST RtI : Tier 1 Tier 2 Tier 3 Has child had educational testing? Your next recommendations include: a) MPH is quite efficacious for school but still not lasting full hours and so decide to prescribe short acting MPH booster dose for after school hours, especially since tolerance of MPH at robust dosing has not been an issue. b) Refer parent to behavioral therapist for parent management training to better address anger management and the persistent defiant behaviors still demonstrated at home. c) Academically, there is minimal improvement despite adequately controlled ADHD symptoms and so you help parent advocate for school proceeding with full psychoeducational evaluation since there may be underlying learning disability. d) You review sleep hygiene and consider OTC melatonin for initial sleep aid. 6) On the third follow up visit, Vanderbilt teacher and parent rating scales reflect notable improvement. However, his appetite has markedly diminished but mom is reluctant to make any changes at this time since efficacy is quite good. Consequently, your next recommendations may include the following statements:
4 a) Counsel on high protein and high calorie nutrition to help him regain his weight loss. b) Initially review his growth curve and though he has lost 4 pounds reassure parent he remains overweight between 90 to 95 th percentile. c) Discuss with parent that if weight decreases to the point of crossing significant weight percentiles, may need to consider alternative medication management. 7) On the fourth follow up visit, parent and teacher Vanderbilt rating scales reflect continued efficacy but weight loss has continued and he has now lost total of 12 pounds which is now worrying parent. Mom worried lowering his total daily dose of MPH will lose efficacy. Hence at this juncture remaining medication management options include: a) Trial of Vyvanse since also hour duration of effect and may be better tolerated and equally or better efficacious. b) Present again option of augmenting with guanfacine ER to allow for dose reduction in total daily dose of MPH. c) Adjunctive use of Risperdal to help him gain weight. 8) Mom opted to try Vyvanse as monotherapy. On the fifth follow up visit, parent and teacher rating scales reflect satisfactory ADHD symptom management. She brings copy of his school testing results and they revealed the following: WISC IV with Verbal IQ SS 94 Perceptual Reasoning SS 100 Working Memory SS 78 Processing Speed 80 (mean is 100). Academic Achievement testing on WJ III were as follows Reading Composite 80 (Basic reading 83, Fluency 78, Reading comprehension 82), Math 92, and Writing 91 (mean is 100). You discuss results with parent and school IEP team has appeared to recommend and IEP under Specific Learning disability for which subject? a) Reading b) Math c) Writing 9) What is striking about his Working Memory management and Processing Speed in comparison to his Verbal and Nonverbal IQ scores? Is this normal?
5 10) What other categories of IEP eligibility may be considered for a youngster with ADHD? OHI and Emotional Disturbed CASE 2 Owen is a former 33 week preterm infant with previously diagnosed ADHD in He is new to your practice following a change in family s insurance coverage, his prior PCP had provided medication management starting since 2014 but no longer in network. Owen s mom reported unsuccessful past trials with Vyvanse and Intuniv. Side effects with Focalin XR were reported including rash around lips, onset of motor tics
6 and throat clearing, and compulsive smelling of self. Now at 7 years of age, weighing 31 kg, and he most recently had been prescribed Adderall 15 mg BID and review of behavior rating scales reveal it has been partially efficacious. A mild rash to lips was reported to recur but with notable decrease in appetite and recent weight loss of 8 pounds. At home he remains impulsive and loud; he is still easily distracted, and moody sometimes (i.e. angry and emotional); OC tendencies and motor and vocal tics began with stimulant medication and have persisted even off the stimulants along with some compulsive behaviors. Gathered behavior rating scales indicate mild breakthrough of ADHD related behaviors on his current medication regimen. On a DSM-oriented rating scale, parent endorsed 3/9 symptoms of inattention and 4/9 symptoms of hyperactivity/impulsiveness. No other behavior management concerns reflected on screening behavioral inventory, including no symptoms of ODD, no depression, and no overt anxiety at home. However, he is fearful about certain things and hypervigilant about police following a break in at his GF's neighbor's house. He is also fearful of thunderstorms. On gathered behavior rating scales, his teacher endorsed 5/9 symptoms of inattention and 6/9 symptoms of hyperactivity and impulsivity. His first grade teacher reported relationship with peers, following direction, and disruptiveness in class are all still problematic. Teacher s recorded responses also seem to perceives Owen as anxious in classroom. There are also ongoing academic struggles and currently failing math. 1) Along with ADHD combined subtype, what other co morbid conditions should be screened given clinical history already provided? 2) Given his prematurity, is there increased risk for neurodevelopmental disability? If, so what kind of problems are often encountered? 3) Do stimulant cause tics? Are they not contraindicated? If tics become problematic what recommendations would you consider giving to parent about her son s ADHD management? 4) Given his ongoing academic struggles what should you recommend to this parent to help with management of ADHD in classroom setting and academics? 5) Vanderbilt parent and teacher rating scales reflected partial efficacy with Adderall but given side effect complaints of appetite suppression and weight loss, mom is receptive to trying alternative stimulant medication. Which long-acting stimulant medication would you select next? 6) What instrument for further assessment at the primary care level should you consider to help better assess degree of anxiety? 7) Four weeks later with Ritalin LA dose titrated to 40 mg, parent and teacher Vanderbilt scores endorse satisfactory ADHD symptom management. However, he is demonstrating rebound moodiness that occurs after school hours. Generally, he has a window of about an hour to finish homework before
7 medication completely wears off. Mom completed SCARED and ends up revealing minimal of anxiety related behaviors. Owen also broke out with "allergy" around his mouth just like before with stimulants. Further inquiry reveals he is frequently licking his lips. VANDERBILT REPORT: PARENT: Symptoms of Inattention (i.e., items with score = 2 or 3): 4 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 2 out of 9 TOTAL SCORE: 6 TEACHER: Symptoms of Inattention (i.e., items with score = 2 or 3): 2 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 1 out of 9 TOTAL SCORE: 3 SCREEN FOR CHILDREN'S ANXIETY RELATED DISORDERS (SCARED): The SCARED is a questionnaire comprised of 41 statements about how people feel. Each statement is rated according to how true it has been over the preceding 3 months. Possible responses for each statement are: 0 (Not True or Hardly Ever True) 1 (Somewhat True of Sometimes True), or 2 (Very True or Often True). One form is designed for the child to complete; a separate form is for a parent to complete. Significant Total Score (>25) indicates high likelihood of an anxiety disorder. Subtypes of anxiety are assessed by tallies of specific questions; risk of having each subtype is considered high if the cutoff (in parentheses) for that subtype is exceeded. Parent's ratings: Panic/Somatic (7): 1 Gen. Anxiety Disorder (9): 6 Separation Anxiety (5): 3 Social Anxiety (8): 1 School Avoidance (3): 1 TOTAL (25): 12
8 What changes in any in medication management would you consider at this juncture? What is the general maneuver from a medication standpoint to help with rebound moodiness? Is it surprising with stimulants for kids with anxious disposition or OCD tendencies to experience exacerbation of anxiety/ocd tendencies? Mom pleased with efficacy and overall tolerance to MPH compared to other stimulants previously tried and so discussed options with dosing. Can lower MPH dose to help reduce the compulsive lip licking and add guanfacine for adjunctive dose to help make up the difference in ADHD symptom control or can try different MPH formulation and switch from Ritalin LA (50/50) to Metadate CD (30/70). 8) Mom opted to first try Metadate CD formulation before having to add a second ADHD medication for augmentation. There was adequate tolerance to medication, and tics seem to persist intermittently but with slight increase observed at this visit. He seemed to do very well with Metadate CD 40 for first 2 weeks and now seeing steady increase of breakthrough ADHD related behaviors. Comparing Ritalin LA to Metadate CD, mom thought Owen did better in school performance with the 50/50 distribution but appetite was much more significantly diminished at the 40 mg/day of Ritalin LA. Mom completed Vanderbilt in follow up visit today and brought updated one from teacher. Now what do you recommend? VANDERBILT REPORT: PARENT: Symptoms of Inattention (i.e., items with score = 2 or 3): 5 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 4 out of 9 TOTAL SCORE: 9 TEACHER: Symptoms of Inattention (i.e., items with score = 2 or 3): 3 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 3 out of 9 TOTAL SCORE: 7 Although stimulants are first-line treatment of ADHD based on established robust efficacy, there are various indication for the use of FDA-approved nonstimulant medications for children aged > 6 years. In this case an alpha-adrenergic agonist may be prescribed as monotherapy, or in cases of partial stimulant response, guanfacine can be used as augmentative to stimulant medication. So monotherapy even at robust MPH dosing was not enough to adequately sustained ADHD symptom control. Consequently mom was ready to proceed with adjunctive use of guanfacine to better target ADHD related behaviors and once at maintenance dose can consider switching back to Ritalin LA formulation at even possibly at reduced dose for less impact on appetite. May need to consider swapping out MPH for another stimulant which worked well in past until developed tachyphylaxis if it appears same is occurring with MPH. Vocal tics were more continue to monitor and might even garner further reduction of tics with guanfacine on board. His anxiousness is stable and if can ultimately back down on stimulant dose, likely will see less of his compulsive behaviors. Plan is to continue Metadate CD 40 mg/day. Due to cost at this time, added guanfacine 1/2 tabs in AM and PM to better target ADHD related behaviors.
9 9) At his now fifth follow up visit, Mom reports improved target symptoms with the addition of guanfacine, but ADHD symptom control is not yet optimal in classroom setting. Metadate CD typically lasts long enough for HW time before wearing off so that the 1/2 mg of guanfacine near dinner time is sufficiently helpful but not enough for school. Vocal tics have increased in frequency and teacher complaining they are distracting to other children in classroom. Owen is fearful he will get in trouble in school for being disruptive. Mom inquiring if she should pursue behavioral therapy to help him with self-regulation and further reduction of impulsiveness. On gathered behavior rating scales, his teacher endorsed 6/9 symptoms of inattention and 5/9 symptoms of hyperactivity and impulsivity. He continues to rush through his work, he remains disorganized, and requiring lots of redirection to remain on task. Academically he continues to struggle and he is performing 1 to 2 years below grade level. Still no RtI or Section 504 plan in place. Now what would you recommend? VANDERBILT REPORT: PARENT: Symptoms of Inattention (i.e., items with score = 2 or 3): 3 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 2 out of 9 TOTAL SCORE: 5 TEACHER: Symptoms of Inattention (i.e., items with score = 2 or 3): 6 out of 9 Symptoms of Hyperactivity/Impulsivity (i.e., items with score = 2 or 3): 5 out of 9 TOTAL SCORE: 13 Keep Metadate CD at 40 mg, switch short acting guanfacine to ER formulation and get PA. Would continue with titration of Intuniv to better target ADHD symptom control and help further reduce tic frequency. Agree with behavioral therapy but to also address increased anxiousness, coping strategies the promote increased relaxation and self-regulation. CBT for habit reversal is evidence based to help with tic reduction. Monitor level of anxiety and consider having him complete SCARED child version for further assessment if needed. Help advocate for formulation of Section 504 Plan to help with ADHD related behaviors in class and request RtI Tier 2 level of intervention. Ultimately, he may need full IEP and can be considered under OHI secondary to ADHD diagnosis. 10) Two months later with Metadate CD maintained at 40 mg/day and Intuniv titrated to 4 mg, gathered parent and teacher Vanderbilt scores endorse satisfactory ADHD symptom management. Section 504
10 Plan is in place with RtI at Tier 2 and academically appreciating improved progress. ARD meeting is in 2 weeks. Mom s only concern is noticing increased daytime somnolence corroborated by teacher comments on Vanderbilt since dose of Intuniv was increased from 3 to 4 mg/day. He had been taking dose in AM along with his stimulant. What one change would you recommend? Given complaints of increased daytime somnolence experienced with higher dosing of Intuniv at 4 mg, would switch to dinner time or bedtime before considering dose reduction.
ADHD Medications: Basics. David Benhayon MD, PhD
ADHD Medications: Basics David Benhayon MD, PhD Goals & Objectives Understand basic classes of stimulants and equivalents Be exposed to role of nonstimulant alternatives Discuss the role of therapy in
More informationParents Guide to ADHD Medications. Copyright Child Mind Institute
Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27
ADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27 Considering ADHD diagnosis? Problem from inattention/hyperactivity Consider comorbidity or other diagnosis: Oppositional Defiant Disorder Conduct
More informationTrouble shooting medication adjustment and side effect management in children with ADHD
Trouble shooting medication adjustment and side effect management in children with ADHD Drs. Joanna Holland and Sarah Manos 44 th Annual Dalhousie Spring Refresher April 5, 2018 Disclosure We have no disclosures
More informationDEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES
DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES Scott R. Smith, MD, MPH Developmental-Behavioral Pediatrician University of Rochester Medical Center Common Complaints about Children with Problems Your
More informationHumberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor
The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry
More informationAttention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D.
Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. PREVALENCE & STATISTICS 6-8% of all children have ADHD (CDC Statistical Data) Age of onset: 7 years old (Prior DSM-IV) 12 years old (Current
More informationScoring Instructions for the VADTRS:
VANDERBILT ADHD DIAGNOSTIC TEACHER RATING SCALE (VADTRS) Scoring Instructions for the VADTRS: Behaviors are counted if they are scored 2 (often) or 3 (very often). Inattention Hyperactivity/ impulsivity
More informationADHD Explanation 5: Medications used in ADHD
ADHD Explanation 5: Medications The aim of treatment is efficient functioning and achieving goals in life It is most important to find the dose of medications that works best As children grow they may
More informationADHD FOLLOW-UP VISITS FOR STUDENTS IN MIDDLE SCHOOL OR HIGH SCHOOL
BROOKLYN PARK OFFICE (763) 425-1211 FAX (612) 874-2907 CALHOUN OFFICE (952) 562-8787 FAX (612) 874-2909 MAPLE GROVE OFFICE Bass Lake Center (763) 559-2861 FAX (612) 874-2902 PLYMOUTH OFFICE WestHealth
More informationPharmacologic Management of ADHD
Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine
More informationADHD: Beyond the DSM Emotion in ADHD
ADHD: Beyond the DSM ADHD is a common condition: Old data: 3 5% of school age population True incidence 8 10% of population, not just school age Affect millions of American families Impacts almost every
More informationConroe ADHD Solutions
Diagnosis and Medical Management of ADD/ADHD How do we make the diagnosis of ADD/ADHD? We are very careful to be sure we have the diagnosis correct before considering treatment. In the past there were
More informationTreating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers
Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*
More informationAD/HD is a mental disorder, and it often lasts from
short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.
More informationWhat are the most common signs of ADHD? And what are the most common medication interventions?
What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina
More informationScoring Instructions for the VADPRS:
VANDERBILT ADHD DIAGNOSTIC PARENT RATING SCALE (VADPRS) Scoring Instructions for the VADPRS: Behaviors are counted if they are scored 2 (often) or 3 (very often). Predominantly inattentive subtype Predominantly
More informationAsk The Shrink: ADHD
Ask The Shrink: ADHD Theodore A. Petti, MD Professor of Psychiatry Division of Child and Adolescent Psychiatry Robert Wood Johnson Medical School PPC Hub Psychiatrist Hackensack Meridian Hubs @ Saint Peter'
More informationMental Health. Integration. School Baseline Evaluation Packet. The school has my permission to return forms directly to the clinic.
Mental Health Integration School Baseline Evaluation Packet To be filled out by physician/office staff Today s Date: Student s Name: Physician Name: Clinic Name: Clinic Address: Student s Phone: Clinic
More informationThe Use of ADHD Medication in the Pediatric Population
The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications
More informationSnohomish Middle School 321 West B Street Snohomish, Wa Initial Evaluation
Angela Deering 6 th grade DOB: 1/17/1999 Age 11 Snohomish Middle School 321 West B Street Snohomish, Wa 98297 Initial Evaluation Evaluation Team: Sarah Pemble, School Psychologist Nurse Miles Ms. Truman,
More informationSAMPLE. Conners 3 Parent Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Parent Assessment Report SAMPLE This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any
More informationSAMPLE. Conners 3 Self-Report Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Self-Report Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other
More informationAttention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD
Attention Deficit Hyperactivity Disorder State of the Art Christopher Okiishi, MD What is ADHD? Three subtypes: Inattentive (under diagnosed, esp. in girls) Hyperactive Impulsive Combined Impairments must
More informationNICHQ Vanderbilt Assessment Follow-up PARENT Informant
D5 NICHQ Vanderbilt Assessment Follow-up PARENT Informant Today s Date: Child s Name: Date of Birth: Parent s Name: Parent s Phone Number: Directions: Each rating should be considered in the context of
More information23/06/2015. Absolutely none!!
Absolutely none!! Child and adolescent Mental Health can we help? Dr Tina Nicholson CCFP Family Practitioner and Medical Lead, Cochrane Clinical Lecturer Dept Family Med. U of C. Member of CanReach Faculty
More informationADHD: Management Update
4/5/17 Conflicts of Interest ADHD: Management Update I have no conflicts to disclose. Jennifer R. Walton, MD, MPH, FAAP April 7, 2017 ADHD: DSM-5 Definition Objectives To briefly review ADHD diagnostic
More informationSAMPLE REPORT. Conners 3 Parent Short Form Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Parent Short Form Assessment Report SAMPLE REPORT This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the
More informationSAMPLE. Conners 3 Self-Report Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Self-Report Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other
More informationAttention Deficit Hyperactivity Disorder in Children and Adults
Attention Deficit Hyperactivity Disorder in Children and Adults Steven R. Pliszka, MD Professor and Chair Department of Psychiatry The University of Texas Health Science Center at San Antonio Speaker Disclosure
More informationBeyond Sleep Hygiene: Behavioral Approaches to Insomnia
Beyond Sleep Hygiene: Behavioral Approaches to Insomnia Rocky Garrison, PhD, CBSM Damon Michael Williams, RN, PMHNP-BC In House Counseling Laughing Heart LLC 10201 SE Main St. 12 SE 14 th Ave. Suite 10
More informationExternalizing Disorders
Externalizing Disorders Psychology 311 Abnormal Psychology Listen to the audio lecture while viewing these slides 1 Background Many types ADHD Oppositional Defiant Disorder Tourette Disorder Others Includes
More informationRecognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives
Southern California Permanente Medical Group Pediatric Symposium Hyatt, Long Beach CA. 11/1/13 Recognition and Treatment of ADHD in Primary Care Settings Martin T. Stein, M.D. Professor of Pediatrics Division
More informationMCPAP Clinical Conversations: Attention Deficit/Hyperactivity Disorder (ADHD) Update: Rollout of New MCPAP ADHD Algorithm
MCPAP Clinical Conversations: Attention Deficit/Hyperactivity Disorder (ADHD) Update: Rollout of New MCPAP ADHD Algorithm Jefferson Prince, MD Co-Medical Director Eastern MCPAP Teams May22, 2018 1 Overview
More informationFebruary 7-9, 2019 The Westin Fort Lauderdale Florida. Provided by
February 7-9, 2019 The Westin Fort Lauderdale Florida Provided by Integrating State-of-the-Art Interventions into Clinical Practice Barbara J. Coffey, MD, MS Division Chief, Child and Adolescent Psychiatry
More informationDrug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Update 5 Report July 2015 The purpose of reports is to make available information regarding the comparative
More informationAdult ADHD. 1. Overview of ADHD 4. Principles for managing ADHD. 2. Common features of ADHD in adults. 3. General approaches to managing ADHD
Adult ADHD 1. Overview of ADHD 4. Principles for managing ADHD 2. Common features of ADHD in adults 3. General approaches to managing ADHD Definition The name... 1. Overview of ADHD Definition Attention
More information18 PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH ADHD
18 PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH ADHD Considering ADHD diagnosis? Problem from inattention/hyperactivity Consider comorbidity or other diagnosis: Oppositional Defiant Disorder Conduct
More informationNICHQ Vanderbilt Assessment Follow-up PARENT Informant
D5 NICHQ Vanderbilt Assessment Follow-up PARENT Informant Today s Date: Child s Name: Date of Birth: Parent s Name: Parent s Phone Number: Directions: Each rating should be considered in the context of
More informationSAMPLE. Conners 3 Teacher Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Teacher Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other
More informationADHD Treatment Options THE GOOD, THE BAD, AND THE UGLY.
ADHD Treatment Options THE GOOD, THE BAD, AND THE UGLY. ADHD is a chronic condition. There is no cure for ADHD. Symptoms may become more manageable with maturity, but a significant number of adults continue
More informationPRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER Attention-Deficit / Hyperactivity Disorder (ADHD). (2017, August 31). Retrieved April 06,
More informationSAMPLE. Conners 3 Comparative Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Conners 3 Comparative Report Parent Teacher Self-Report Child's Name/ID: Cindy Johnson Cindy Johnson Cindy Johnson Administration Date: Jul 31, 2007 Jun 28, 2007 Jul 31, 2007
More informationAttention-Deficit/Hyperactivity Disorder Nathan J. Blum, M.D.
ADHD in Preschool Children Preschool ADHD: When Should We Diagnose it & How Should We Treat it? Professor of Pediatrics Diagnosis of ADHD in Preschool Children: Impact of DSM-IV Is Preschool ADHD Associated
More informationCOUNSELING ASSESSMENT REFERRAL AND BACKGROUND INFORMATION (Adult Form) cell telephones/fax #s/ addresses: (Spouse): (Emergency Contact):
Joanna C. Ioannides, LCSW *Lowry Counseling, LLC *7581 E. Academy Blvd. Ste 209 * Denver, CO 80230*Ph. (720)319-7319 Fax (303)379-4607* counseldenver@aol.com* COUNSELING ASSESSMENT REFERRAL AND BACKGROUND
More informationTHE CARITHERS PEDIATRIC GROUP PEDIATRIC AND ADOLESCENT MEDICINE. Medical History
THE CARITHERS PEDIATRIC GROUP PEDIATRIC AND ADOLESCENT MEDICINE Medical History Birth History: Vaginal or Caesarian section (please circle) Term or premature (please circle) If premature, how many weeks
More informationTo Give or not to Give Medication: That is the Question
To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental
More informationADHD Tests and Diagnosis
ADHD Tests and Diagnosis Diagnosing Attention Deficit Disorder in Children and Adults On their own, none of the symptoms of attention deficit disorder are abnormal. Most people feel scattered, unfocused,
More informationEvidence-Based Assessment in School Mental Health
Evidence-Based Assessment in School Mental Health MASBHC May 19, 2015 Jill Bohnenkamp, Ph.D. Elizabeth Connors, Ph.D. Center for School Mental Health, 2015 University of Maryland, Baltimore Objectives
More informationUpdate on the Treatment of ADHD 2019
Update on the Treatment of ADHD 2019 James H. Beard, Jr., M.D, FAAP Developmental-Behavioral Pediatrician Division of Developmental Pediatrics The Rights of ADHD The right diagnosis of ADHD and co morbidities
More informationADHD and social skills M. T. LAX-PERICALL CONSULTANT IN CHILD AND ADOLESCENT PSYCHIATRY PRIORY HOSPITAL ROEHAMPTON
ADHD and social skills M. T. LAX-PERICALL CONSULTANT IN CHILD AND ADOLESCENT PSYCHIATRY PRIORY HOSPITAL ROEHAMPTON ADHD (DSM-5) persistent pattern of inattention and/or hyperactivity-impulsivity that interferes
More informationEvidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center
Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to
More informationDSM-5 Criteria for ADHD from
DSM-5 Criteria for ADHD from http://www.cdc.gov/ncbddd/adhd/diagnosis.html People with ADHD show a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or
More information29 th Annual Learning Symposium
Friday, January 5, 9 Breakout Session 9 th Annual Learning Symposium ADHD & Medication Steven Pliszka, M.D. Dr. Steven Pliszka is a Dielmann Distinguished Professor and Chair of the Department of Psychiatry
More informationPHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
DYANAVEL XR (amphetamine) extended-release oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit
More informationPractical care of the Child with ADHD Kristina Hingre MD
Practical care of the Child with ADHD Kristina Hingre MD Objectives Know the DSM 5 Criteria for diagnosis of ADHD Identify 4 Comorbidities of ADHD Be familiar with the common ADHD medications and Side
More informationA REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE
A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE OVERVIEW Review Stimulant Treatment for ADHD STIMULANTS
More informationPatient Information Form
1 Today s Date: Patient s Name Date of Birth Your Name Relationship to Child Name of School Grade Teacher(s) Please list the problems with which you want help for this child: 1. 2. 3. 4. 5. 6. 7. Has the
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationAttention Deficit Hyperactivity Disorder Overview and New Perspectives
1st Annual Regional Psychiatry Conference Psychiatry for the Non-Psychiatrist Attention Deficit Hyperactivity Disorder Overview and New Perspectives Thomas B. Henry, MD Board Certified Child & Adolescent
More information28 th Annual Learning Symposium
Friday, January 6, 8 Breakout Session 8 th Annual Learning Symposium ADHD & Medication Steven Pliszka, M.D. Presented by: Steven Pliszka, M.D. Dielmann Distinguished Professor and Chair Department of Psychiatry,
More informationChelsea Murphy MS, NCC. Kennedy Health Systems
Chelsea Murphy MS, NCC Kennedy Health Systems What is ADHD? o Neurobiological Disorder deficit in the neurotransmitters (message senders within the brain) o Dopamine & Norepinephrine are not released as
More informationSAMPLE. Behavior Parent Assessment Report. By C. Keith Conners, Ph.D.
By C. Keith Conners, Ph.D. Behavior Parent Assessment Report This Assessment Report is intended for use by qualified assessors only, and is not to be shown or in any other way provided to the respondent
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More informationChild/Adolescent Attention-Deficit/Hyperactivity Disorder
Child/Adolescent Attention-Deficit/Hyperactivity Disorder NATIONAL GUIDELINE SUMMARY This evidence-based guideline summary is based on the 202 National Child/Adolescent Attention-Defict/ Hyperactivity
More informationADHD in the Preschool Aged Child
ADHD in the Preschool Aged Child (PATS) 11/2/2013 Stephen Meister MD, MHA, FAAP The Edmund N Ervin Pediatric Center (PATS) National Institute of Mental Health study First papers published in 2006 after
More informationADHD: A Focus On Drug Therapy
ADHD: A Focus On Drug Therapy MARY WORTHINGTON, PHARM.D., BCPS MCWHORTER SCHOOL OF PHARMACY BIRMINGHAM, ALABAMA SEPTEMBER 13, 2013 Outpatient Prescription Drug Utilization in US Children, 2002-2010 90
More informationA Closer Look: NH Primary Care Clinician Perspective on Caring for Pediatric Patients with ADHD
A Closer Look: NH Primary Care Clinician Perspective on Caring for Pediatric Patients with ADHD W. Burleson Daviss, MD Dept. of Psychiatry / DHMC Molly O Neil University of New Hampshire Objectives 1)
More informationADHD Part II: Managing Comorbities
ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have
More informationpresented by Dr. Annick Vincent, Clinique du TDAH Institut Universitaire en santé mentale, Centre hospitalier Robert-Giffard Revision : October 2007
Attention Deficit and Hyperactivity Disorder School adaptation in postsecondary education presented by Dr. Annick Vincent, Clinique du TDAH Institut Universitaire en santé mentale, Centre hospitalier Robert-Giffard
More informationOverview of ADHD Symptoms in ID/D
Overview of ADHD Symptoms in ID/D Laura Politte, M.D. Child and Adolescent Psychiatry Carolina Institute for Developmental Disabilities November 8, 2017 Define Define symptoms of ADHD, as defined by DSM-5
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationDate: Child s Name: Date of Birth:
Date: Child s Name: Date of Birth: Dear Parent: Because ADD/ADHD is a chronic condition requiring ongoing medication, it is our policy to follow your child every 6 months to monitor his or her progress
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationADHD ATTENTION-DEFICIT HYPERACTIVITY DISORDER READ. ASK QUESTIONS. THINK. DECIDE.
ADHD ATTENTION-DEFICIT HYPERACTIVITY DISORDER READ. ASK QUESTIONS. THINK. DECIDE. Using this booklet to help READ. ASK QUESTIONS. THINK. DECIDE. If a doctor is evaluating your child for ADHD, this booklet
More informationPrevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand
The 25th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2014 Kota Kinabalu, Sabah, Malaysia 9th - 12th October, 2014 Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit
More informationEDUCATING THE EDUCATORS
EDUCATING THE EDUCATORS A Professional Development Program of NAMI Massachusetts Newburyport School District May 7, 2015 Copyrighted and Developed by NAMI NJ GREAT Teachers are the Product of Nurture and
More informationADHD Packet Medical Drive, Suite 310 l San Antonio, Texas l Tel: l Fax:
ADHD Packet A thorough evaluation is required prior to deciding whether your child has Attention Deficit Hyperactivity Disorder. Once a preliminary assessment can be made then a plan for evaluation and
More informationThe ADHD Journey. Angelina Wiwczor, Nurse Practitioner
The ADHD Journey Angelina Wiwczor, Nurse Practitioner Disclosure * I do not have any conflicts of interest to declare Objectives * 1. Epidemiology of ADHD * 2. Review DSM 5 diagnostic criteria for ADHD
More informationWhat is Tourette Syndrome?
What is Tourette Syndrome? 42-40 Bell Blvd., Suite 205, Bayside, NY 11361 tourette.org 888-4TOURET Tics, Tic Disorders, and Tourette Syndrome Tics are involuntary, repetitive movements and vocalizations.
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More informationI. Diagnostic Considerations (Assessment)...Page 1. II. Diagnostic Criteria and Consideration - General...Page 1
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Attention Deficit/Hyperactivity Disorder in Children and Adolescents Developed March
More informationDrug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Report Update 3 September 2009 Update 2: November 2007 Update 1: May 2006 Original Report: September 2005 The
More information5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development
By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,
More informationPERSONAL HISTORY QUESTIONNAIRE
PERSONAL HISTORY QUESTIONNAIRE Here are several pages of questions that we want you to answer about yourself. Please answer them to the best of your ability, as completely and honestly as you can. Completing
More informationI also hereby give permission to any of the above to share information with Crown Colony Pediatrics about my child.
Crown Colony Pediatrics Barbara E. Angus, M.D. 500 Congress Street, Suite 1F Beata J. Brzozowska, M.D. Quincy, MA 02169 Lisa B. Corkins, M.D. Phone: (617) 471-3411 Fax: (617) 471-3584 Lisa R. Natkin, M.D.
More informationADDES-3 QUICK SCORE SCHOOL VERION PROFILE SAMPLE
ATTENTION DEFICIT DISORDERS EVALUATION SCALE-THIRD EDITIO SCHOOL VERSION RATING FORM PROFILE SHEET SUMMARY OF SCORES Name: Andrew Thomas Gender: Male Raw Standard Standard School: Midvale Middle School
More information6800$5< /,)(7,0( ',$*126(6 &+(&./,67 'DWH RI &XUUHQW BBBB BBBB BBBBBB
Criteria for Probable Diagnosis: 1. Meets criteria for core symptoms of the disorder. 2. Meets all but one, or a minimum of 75% of the remaining criteria required for the diagnosis 3. Evidence of functional
More informationADHD What is it? What can I do? June 22, 2013 Joseph L. Flint, MD Delavan Pediatrics
ADHD What is it? What can I do? June 22, 2013 Joseph L. Flint, MD Delavan Pediatrics Common Questions What is ADHD? Is it real? Isn't it over-diagnosed? What are my options? Will my child be a zombie?
More informationCase Presentation. David Malone. University of Tennessee at Chattanooga SOCW 411. Mrs. Kathy Purnell, MSW
Case Presentation 1 Running head: CASE PRESENTATION Case Presentation David Malone University of Tennessee at Chattanooga SOCW 411 Mrs. Kathy Purnell, MSW February 20, 2008 Case Presentation 2 Case Presentation
More informationPsychopharmacology for Non-MDs - Dr. Suzanne Dieter. March 10, 2017 PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS LEARNING OBJECTIVES
LEARNING OBJECTIVES PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS, MD New York, NY Member, American Academy of Child and Adolescent Psychiatry Understand the role a child psychiatrist can play as part of a
More informationChildhood Anxiety Disorders
Childhood Anxiety Disorders Check-Lists and Descriptions for 5 Anxiety Disorders: Separation Anxiety Disorder Social Phobia Obsessive Compulsive Disorder Specific Phobia Generalized Anxiety Disorder Gregory
More informationPL CE LIVE February 2011 Forum
February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics
More informationA Physician's Perspective
A Physician's Perspective by Theodore Mandelkorn, MD Part one Introduction Who should take medications, and why? What improvement should be seen? Who should prescribe medications? Medical trials What is
More informationStimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information
Adderall and Adderall-XR (amphetamine mixtures) Concerta (methylphenidate, controlled Dexedrine, Dexedrine Spansules (dextroamphetamine) Focalin (dexmethylphenidate) Metadate, Metadate-ER, and Metadate-CD
More informationADHD DIAGNOSIS AND MANAGEMENT
ADHD DIAGNOSIS AND MANAGEMENT Cesar Ochoa, MD Head, Developmental-Behavioral Pediatrics Rush University Medical Center Medical Director, Rush Neurobehavioral Center April 28,2017 LEARNING OBJECTIVES 1.
More informationADHD DIAGNOSIS AND MANAGEMENT LEARNING OBJECTIVES CASE 4/28/2017
ADHD DIAGNOSIS AND MANAGEMENT Cesar Ochoa, MD Head, Developmental-Behavioral Pediatrics Rush University Medical Center Medical Director, Rush Neurobehavioral Center April 28,2017 LEARNING OBJECTIVES 1.
More informationPerspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry
Perspective Truth on ADHD & Medications Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Disclosures National Institute of Health ADHD and Aggression Study Co- Investigator
More information